COMMUNIQUÉS West-GlobeNewswire

Gracell Biotechnologies Acquisition Completed
22/02/2024
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, Nasdaq: GRCL), a global clinical-stage biopharmaceutical company developing [...]
SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference
22/02/2024
BOSTON and ROLLE, Switzerland, Feb. 22, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Co-founder and Chief Executive [...]
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
22/02/2024
-In vivo data supports BAER-101’s unique ability to significantly suppress seizures using the SynapCell's Genetic Absence Epilepsy Rat from Strasbourg (“GAERS”) model of absence epilepsy- MIAMI, Feb. 22, 2024 (GLOBE [...]
Cerevance to Participate at the TD Cowen 44th Annual Health Care Conference
22/02/2024
BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced participation at the upcoming TD Cowen 44 th [...]
AssureCare Revolutionizes Pharmacist Credentialing with Groundbreaking Solution
22/02/2024
AssureCare’s AssureRx platform enables pharmacies to navigate the complexities of pharmacist credentialing with a comprehensive, seamless solution CINCINNATI, Feb. 22, 2024 (GLOBE NEWSWIRE) -- AssureCare, a leading [...]
Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium
22/02/2024
SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, [...]
Ashvattha Therapeutics Announces First Patient Enrolled in Expanded Phase 1/2 Study of Imaging Agent 18F-OP-801 in Additional Neurological Indications
22/02/2024
The study will evaluate the safety, tolerability, and ability of 18 F-OP-801 to cross the blood-brain barrier and selectively target neuroinflammation in individuals with amyotrophic lateral sclerosis, Alzheimer’s [...]
Umoja Biopharma to Participate in a Fireside Chat at the Evercore ISI 2024 Emerging Biotech Conference
22/02/2024
SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR T cell therapies [...]
Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29
22/02/2024
Company to Host Conference Call, February 29, 2024 at 4:30 p.m. ET SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome- [...]
Safety Shot’s Jupiter Wellness Legacy Assets Licensed to Elite Health Partners: Safety Shot to Dividend 40% of Post-IPO Wellness Powerhouse To Its Shareholders
22/02/2024
Elite Health Partners is a manufacturer, marketer, and distributor of health and beauty products via its 3PL logistics and fulfillment center. License of Jupiter Wellness assets to convert to purchase by Elite Health [...]
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
22/02/2024
PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot study for the Company’s [...]
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
22/02/2024
BERKELEY, Calif. and MAINZ, Germany, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, [...]
Amfora Launches First Commercial Products
22/02/2024
Company’s soy flour contains more than 60 percent protein SAN FRANCISCO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Amfora, a company developing products to sustainably nourish the planet and enhance global wellness, today [...]
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair
22/02/2024
WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the special meeting of the shareholders of the Company held [...]
Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024
22/02/2024
DALLAS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company ”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
22/02/2024
SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating [...]
Lisata Therapeutics to Host Year-End 2023 Conference Call on Thursday, February 29, 2024 at 4:30 p.m. Eastern Time
22/02/2024
BASKING RIDGE, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of [...]
Notice of Nexstim Plc’s 2023 Full Year Results
22/02/2024
Press release, Helsinki, 22 February 2024 at 3 P M (EET) Notice of Nexstim Plc’s 2023 Full Year Results Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") will announce its full year results for the year ended 31 December [...]
Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
22/02/2024
REDWOOD CITY, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]

Pages